What is the long-term trend for Palvella Therapeutics's operating lease liabilities (current)?

Over 5 years (2020 to 2025), Palvella Therapeutics's operating lease liabilities (current) has grown at a -27.8% compound annual growth rate (CAGR), from $1.03M to $202K.

What does operating lease liabilities (current) mean?

The current portion of operating lease obligations due within one year, representing committed future lease payments under ASC 842.

Palvella Therapeutics PVLA Operating Lease Liabilities (Current)

Operating Lease Liabilities (Current) at other companies

Relay Therapeutics, Inc.RLAY

$3.89M-34.4%

Viridian Therapeutics, Inc.VRDN

$738K+37.7%

PrecigenPGEN

$1.07M+15.1%

Kodiak Sciences IncKOD

$11.66M+6.5%

Ligand PharmaceuticalsLGND

$1.09M+26.7%

BridgeBio PharmaBBIO

$4.44M-14.8%

Other financials

Income statement

See full

Revenue$53.0K-97.3%

Operating income-$14.9M-88.7%

Net income-$15.8M-92.6%

EPS (diluted)-$1.20-62.2%

Balance sheet

See full

Cash & equivalents$206.4M+173%

Total debt$584.0K—

Total equity$232.3M+318%

Total assets$263.8M+232%

Cash flow

See full

Operating cash flow-$10.9M-60.5%

CapEx--100%

Free cash flow-$2.7M+72.0%

Valuation

See full

Market cap$1.7B+468%

Enterprise value$1.5B—

P/S41.6×—

Profitability

See full

Operating margin-183.2%-13.5pp

Net margin71.7%+40.4pp

FCF margin-99.8%-34.2pp

Returns & leverage

See full

Return on equity-34.2%—

Debt / equity0×—

Current ratio28.9×+20.0×

Where this comes from

Reported directly by Palvella Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:OperatingLeaseLiabilityCurrent.

The official record: Palvella Therapeutics’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Palvella Therapeutics's operating lease liabilities (current).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Palvella Therapeutics's operating lease liabilities (current)?: Palvella Therapeutics (PVLA) reported operating lease liabilities (current) of $209K in Q1 2026.
What is the long-term trend for Palvella Therapeutics's operating lease liabilities (current)?: Over 5 years (2020 to 2025), Palvella Therapeutics's operating lease liabilities (current) has grown at a -27.8% compound annual growth rate (CAGR), from $1.03M to $202K.
What does operating lease liabilities (current) mean?: The current portion of operating lease obligations due within one year, representing committed future lease payments under ASC 842.